Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing ...

The Greeks who hold the keys to JP Morgan Chase, Costco, Pfizer, Fendi, Duke Energy, the banker who saved the US economy in ...

The pharma executive is optimistic about the new US administration but is also realistic about the risks that come with "radical change." ...

PF-07976016 is under clinical development by Pfizer and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) indication ...

The announcement came days after Netanyahu said in a video address that Israel would be able to sign a deal with Pfizer in part because the company’s CEO, Albert Bourla, told Netanyahu he is ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.

Pfizer PFE-0.49%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.95%decrease; red down pointing triangle for 2.50 billion ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer recently discussed. In a recent episode of CNBC's Squawk On The Street, Jim ...

Other previous laureates have included Michael Bloomberg, Itzhak Perlman, Ruth Bader Ginsburg, and Albert Bourla. The foundation has given more than $50 m. to philanthropic causes around the world ...

Its high debt load remained a cause of investor concern for the entire year, and as a result, CEO Albert Bourla’s turnaround strategy is now a key part of Pfizer Inc. (NYSE:PFE)’s hypothesis.